New pill aims to lower uric acid in kidney patients
Disease control
Recruiting now
This study tests an experimental tablet called IG3018 in 60 adults with high uric acid, some of whom also have chronic kidney disease. The main goals are to check the drug's safety and see how well it lowers uric acid levels over 4 weeks. Participants will receive different doses…
Phase: PHASE1, PHASE2 • Sponsor: Intelligem Therapeutics Australia Pty Ltd. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC